Next Steps For NuVasive Following CEO Resignation
This article was originally published in The Gray Sheet
The resignation of CEO Alex Lukianov could signal a shift in the spine firm's approach to sales and profitability that could ultimately make NuVasive as a more attractive acquisition candidate.
You may also be interested in...
NuVasive says Ellipse's magnetically adjustable implant systems will open new global markets, particularly in the pediatric space, and complement its current portfolio. Analysts say the move is positive, but at least one observer believes that NuVasive might have paid too much for the deal.
Hill-Rom's acquisition of Welch Allyn speeds ahead; Nuvasive builds its team; Philips divests pediatric respiratory products.
NuVasive and Delcath Systems appoint CEOs. Boston Scientific Corp. names senior medical director, rhythm management. Silk Road Medical Inc. appoints executive VP, global sales. Si-Bone taps CFO.